Cite
Cho YS, Levell JR, Liu G, et al. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS Med Chem Lett. 2017;8(10):1116-1121doi: 10.1021/acsmedchemlett.7b00342.
Cho, Y. S., Levell, J. R., Liu, G., Caferro, T., Sutton, J., Shafer, C. M., Costales, A., Manning, J. R., Zhao, Q., Sendzik, M., Shultz, M., Chenail, G., Dooley, J., Villalba, B., Farsidjani, A., Chen, J., Kulathila, R., Xie, X., Dodd, S., Gould, T., Liang, G., Heimbach, T., Slocum, K., Firestone, B., Pu, M., Pagliarini, R., & Growney, J. D. (2017). Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS medicinal chemistry letters, 8(10), 1116-1121. https://doi.org/10.1021/acsmedchemlett.7b00342
Cho, Young Shin, et al. "Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor." ACS medicinal chemistry letters vol. 8,10 (2017): 1116-1121. doi: https://doi.org/10.1021/acsmedchemlett.7b00342
Cho YS, Levell JR, Liu G, Caferro T, Sutton J, Shafer CM, Costales A, Manning JR, Zhao Q, Sendzik M, Shultz M, Chenail G, Dooley J, Villalba B, Farsidjani A, Chen J, Kulathila R, Xie X, Dodd S, Gould T, Liang G, Heimbach T, Slocum K, Firestone B, Pu M, Pagliarini R, Growney JD. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121. doi: 10.1021/acsmedchemlett.7b00342. eCollection 2017 Oct 12. PMID: 29057061; PMCID: PMC5641959.
Copy
Download .nbib